All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

sodium picosulfate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
	4779	10040-45-6

Description:

Molecule	Description
Synonyms: sodium picosulfate picosulfate sodium picosulfol rapilax picolax	contains two active ingredients, sodium picosulfate and magnesium citrate, which are both laxatives; structure Molecular weight: 481.40 Formula: C18H13NNa2O8S2 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: 145.75 ALOGS: ROTB: None

Drug dosage:

Dose	Unit	Route
5	mg	O

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

Date	Agency	Company	Orphan
July 16, 2012	FDA	FERRING PHARMS AS

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Food allergy	457.96	22.45	165	13691	25313	90589278
Immunodeficiency	379.86	22.45	167	13689	43067	90571524
Overdose	337.31	22.45	240	13616	157469	90457122
Intentional product misuse	313.94	22.45	186	13670	89418	90525173
Temperature regulation disorder	267.78	22.45	96	13760	14483	90600108
Prescribed overdose	249.63	22.45	166	13690	97459	90517132
Hyperhidrosis	249.59	22.45	189	13667	136116	90478475
Foetal death	218.00	22.45	91	13765	20632	90593959
Exposure during pregnancy	138.28	22.45	176	13680	238234	90376357
Cognitive disorder	115.40	22.45	91	13765	69316	90545275
Fluid retention	114.22	22.45	100	13756	87991	90526600
Creatinine renal clearance increased	109.90	22.45	34	13822	3247	90611344
Hypertension	107.52	22.45	224	13632	457308	90157283
Hyponatraemia	102.80	22.45	114	13742	133424	90481167
Renal function test abnormal	101.33	22.45	39	13817	7152	90607439
Reduced facial expression	96.35	22.45	29	13827	2524	90612067
Listless	93.56	22.45	30	13826	3219	90611372
Creatinine renal clearance decreased	92.67	22.45	49	13807	18850	90595741
Product use issue	92.45	22.45	174	13682	329745	90284846
Hepatic enzyme increased	92.24	22.45	183	13673	360553	90254038
Sedation complication	88.99	22.45	46	13810	16898	90597693
Urinary retention	84.03	22.45	59	13797	37685	90576906
Rash erythematous	82.55	22.45	73	13783	65031	90549560
Constipation	82.42	22.45	151	13705	280244	90334347
Coeliac disease	81.78	22.45	62	13794	44548	90570043
Multiple drug therapy	77.80	22.45	32	13824	6977	90607614
Apathy	72.84	22.45	35	13821	11005	90603586
Decreased immune responsiveness	67.81	22.45	31	13825	8717	90605874
Psoriasis	67.14	22.45	97	13759	147657	90466934
Blood calcium decreased	66.76	22.45	47	13809	30135	90584456
Cholestatic liver injury	65.93	22.45	24	13832	3773	90610818
Ileus	62.17	22.45	36	13820	16510	90598081
Orthostatic hypotension	61.36	22.45	51	13805	41776	90572815
Thrombocytopenia	58.26	22.45	110	13746	208615	90405976
Infusion related reaction	58.01	22.45	167	13689	416613	90197978
Depressed level of consciousness	55.72	22.45	62	13794	72722	90541869
Hypersensitivity	55.56	22.45	174	13682	454503	90160088
Sedation	55.13	22.45	51	13805	48120	90566471
Head discomfort	54.72	22.45	33	13823	16300	90598291
Off label use	53.27	22.45	318	13538	1101934	89512657
Drug interaction	53.06	22.45	125	13731	276328	90338263
Upper respiratory tract infection	52.20	22.45	80	13776	128238	90486353
Foreign body	51.77	22.45	18	13838	2476	90612115
Altered state of consciousness	49.50	22.45	40	13816	31492	90583099
Immobile	47.48	22.45	22	13834	6376	90608215
Prescription drug used without a prescription	47.10	22.45	18	13838	3237	90611354
Hypokalaemia	46.79	22.45	77	13779	131039	90483552
Pyrexia	45.91	22.45	211	13645	660274	89954317
Peripheral swelling	45.60	22.45	5	13851	413101	90201490
Arthralgia	43.96	22.45	33	13823	778489	89836102
Alopecia	43.63	22.45	11	13845	495060	90119531
Drug abuse	43.26	22.45	58	13798	82289	90532302
Abdominal discomfort	41.30	22.45	11	13845	477317	90137274
Sinusitis	40.96	22.45	3	13853	343085	90271506
Joint swelling	40.43	22.45	168	13688	503132	90111459
Affect lability	37.34	22.45	27	13829	18036	90596555
General physical health deterioration	37.14	22.45	129	13727	354986	90259605
Product prescribing error	36.60	22.45	33	13823	30112	90584479
Swelling	35.60	22.45	10	13846	419048	90195543
Inappropriate antidiuretic hormone secretion	35.49	22.45	27	13829	19478	90595113
Drug ineffective	34.90	22.45	103	13753	1384195	89230396
Fracture	34.64	22.45	28	13828	22048	90592543
Dehydration	34.14	22.45	85	13771	194362	90420229
Weight increased	33.64	22.45	11	13845	417916	90196675
Nasopharyngitis	32.27	22.45	11	13845	407093	90207498
Pelvic fracture	32.04	22.45	23	13833	15196	90599395
Balance disorder	31.94	22.45	55	13801	97025	90517566
Delirium	30.33	22.45	56	13800	104303	90510288
Bursitis	29.08	22.45	63	13793	131591	90483000
Restlessness	28.31	22.45	31	13825	35689	90578902
Encephalopathy	27.96	22.45	35	13821	46409	90568182
Oxygen saturation decreased	27.93	22.45	55	13801	107428	90507163
Abdominal rigidity	26.29	22.45	11	13845	2501	90612090
Blister	25.92	22.45	4	13852	254994	90359597
Paraesthesia	25.28	22.45	4	13852	250322	90364269
Electrolyte imbalance	24.98	22.45	24	13832	23721	90590870
Bedridden	24.75	22.45	18	13838	12130	90602461
Psoriatic arthropathy	24.58	22.45	3	13853	228332	90386259
Pruritus	24.55	22.45	28	13828	541497	90073094
Fall	24.37	22.45	141	13715	481669	90132922
Depression	24.02	22.45	8	13848	300593	90313998
Asthenia	23.76	22.45	28	13828	533723	90080868
Retching	23.31	22.45	21	13835	19138	90595453
Chest pain	23.06	22.45	10	13846	319635	90294956
Product dose omission issue	22.90	22.45	8	13848	291679	90322912
Paraneoplastic rash	22.55	22.45	5	13851	128	90614463

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Appendicolith	437.31	19.43	163	13241	13293	42594638
Appendicitis	389.54	19.43	169	13235	20444	42587487
Blood phosphorus increased	308.20	19.43	124	13280	12401	42595530
Ventricular fibrillation	302.59	19.43	160	13244	29963	42577968
General physical health deterioration	280.39	19.43	288	13116	150958	42456973
Cardiogenic shock	280.07	19.43	161	13243	35479	42572452
Abdominal distension	260.17	19.43	200	13204	71535	42536396
Ascites	243.49	19.43	175	13229	56503	42551428
Stress	243.13	19.43	159	13245	44053	42563878
Myasthenia gravis	206.49	19.43	101	13303	16036	42591895
Hyponatraemia	201.91	19.43	201	13203	101261	42506670
Blood uric acid increased	186.11	19.43	93	13311	15454	42592477
Multiple organ dysfunction syndrome	170.80	19.43	180	13224	96855	42511076
Dry mouth	168.54	19.43	122	13282	39757	42568174
Hyperphosphataemia	168.17	19.43	82	13322	12922	42595009
Blood cholesterol increased	156.30	19.43	100	13304	26641	42581290
Incorrect route of product administration	144.80	19.43	92	13312	24213	42583718
Abdominal pain	144.52	19.43	233	13171	190238	42417693
Constipation	136.19	19.43	208	13196	162083	42445848
Iron deficiency	131.87	19.43	66	13338	10995	42596936
Hypophosphataemia	131.57	19.43	82	13322	20863	42587068
Bacterial infection	130.94	19.43	91	13313	27788	42580143
Sleep disorder therapy	128.36	19.43	56	13348	6838	42601093
Neuralgia	123.46	19.43	85	13319	25562	42582369
Drug therapy	116.11	19.43	51	13353	6329	42601602
Diabetes mellitus	104.74	19.43	111	13293	59976	42547955
Sepsis	96.60	19.43	201	13203	199133	42408798
Somnolence	92.67	19.43	162	13242	140943	42466988
Vomiting	91.36	19.43	247	13157	289476	42318455
Swelling	74.43	19.43	89	13315	54796	42553135
Thrombosis	66.21	19.43	94	13310	68417	42539514
Chronic obstructive pulmonary disease	66.08	19.43	90	13314	63024	42544907
Intentional product misuse	65.92	19.43	89	13315	61811	42546120
Antacid therapy	64.74	19.43	31	13373	4686	42603245
Aortic stenosis	64.58	19.43	38	13366	8707	42599224
Nausea	63.19	19.43	269	13135	396530	42211401
Sleep disorder	61.96	19.43	76	13328	48019	42559912
Bacteroides infection	61.47	19.43	25	13379	2562	42605369
Anticoagulant therapy	56.81	19.43	28	13376	4507	42603424
Drug intolerance	56.19	19.43	95	13309	80329	42527602
Drug ineffective	54.92	19.43	71	13333	630126	41977805
Activated partial thromboplastin time prolonged	54.57	19.43	43	13361	15860	42592071
End stage renal disease	50.94	19.43	42	13362	16516	42591415
Ulcer	49.11	19.43	41	13363	16400	42591531
Anaemia	47.61	19.43	194	13210	280084	42327847
Drug hypersensitivity	42.02	19.43	95	13309	99294	42508637
Dehiscence	41.27	19.43	13	13391	633	42607298
Total lung capacity decreased	38.74	19.43	20	13384	3550	42604381
Fatigue	35.89	19.43	51	13353	435590	42172341
Pulmonary embolism	34.56	19.43	99	13305	119513	42488418
Hyperlipidaemia	34.38	19.43	38	13366	21478	42586453
Troponin increased	32.78	19.43	35	13369	19027	42588904
Gout	32.40	19.43	42	13362	28013	42579918
Blood calcium increased	31.48	19.43	24	13380	8430	42599501
Lung opacity	27.25	19.43	19	13385	5818	42602113
Rash	26.33	19.43	29	13375	276925	42331006
Toxicity to various agents	25.27	19.43	21	13383	229115	42378816
Condition aggravated	25.25	19.43	154	13250	260600	42347331
Arthralgia	24.95	19.43	17	13387	205221	42402710
Cholestatic liver injury	24.49	19.43	15	13389	3694	42604237
Abdominal neoplasm	24.25	19.43	8	13396	452	42607479
Ileus	24.23	19.43	30	13374	19109	42588822
Bronchopulmonary aspergillosis allergic	23.91	19.43	16	13388	4582	42603349
Analgesic therapy	23.15	19.43	18	13386	6506	42601425
Blood test abnormal	22.73	19.43	24	13380	12882	42595049
Neuropathy peripheral	19.74	19.43	4	13400	101849	42506082
Faecaloma	19.48	19.43	16	13388	6254	42601677

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Appendicolith	498.20	19.75	169	25713	14086	110549331
Appendicitis	427.25	19.75	182	25700	28282	110535135
Blood phosphorus increased	336.07	19.75	131	25751	16209	110547208
Ventricular fibrillation	321.81	19.75	168	25714	41145	110522272
Hyponatraemia	294.85	19.75	306	25576	217347	110346070
Ascites	282.06	19.75	207	25675	92601	110470816
Cardiogenic shock	270.46	19.75	168	25714	57170	110506247
General physical health deterioration	257.68	19.75	400	25482	424895	110138522
Constipation	229.97	19.75	346	25536	357440	110205977
Myasthenia gravis	228.35	19.75	108	25774	21403	110542014
Blood uric acid increased	207.01	19.75	101	25781	21428	110541989
Abdominal distension	199.81	19.75	225	25657	174878	110388539
Hyperphosphataemia	198.01	19.75	90	25792	16291	110547126
Multiple organ dysfunction syndrome	176.57	19.75	197	25685	151513	110411904
Stress	175.60	19.75	166	25716	105182	110458235
Intentional product misuse	174.63	19.75	184	25698	132720	110430697
Sleep disorder therapy	164.64	19.75	63	25819	7408	110556009
Hypophosphataemia	153.32	19.75	96	25786	33086	110530331
Drug therapy	151.82	19.75	59	25823	7232	110556185
Iron deficiency	137.73	19.75	73	25809	18403	110545014
Temperature regulation disorder	134.89	19.75	64	25818	12762	110550655
Bacterial infection	133.73	19.75	100	25782	45936	110517481
Sepsis	130.08	19.75	256	25626	327090	110236327
Neuralgia	116.24	19.75	94	25788	48384	110515033
Diabetes mellitus	113.76	19.75	128	25754	99253	110464164
Food allergy	113.56	19.75	66	25816	19882	110543535
Foetal death	112.87	19.75	61	25821	15984	110547433
Abdominal pain	111.60	19.75	317	25565	512672	110050745
Incorrect route of product administration	104.89	19.75	100	25782	63961	110499456
Somnolence	104.36	19.75	221	25661	297228	110266189
Creatinine renal clearance increased	92.36	19.75	34	25848	3591	110559826
Antacid therapy	88.68	19.75	37	25845	5447	110557970
Anticoagulant therapy	79.46	19.75	34	25848	5327	110558090
Ileus	78.81	19.75	62	25820	30667	110532750
Altered state of consciousness	77.79	19.75	81	25801	57545	110505872
Renal function test abnormal	77.18	19.75	39	25843	8907	110554510
Aortic stenosis	76.44	19.75	44	25838	13015	110550402
Vomiting	76.15	19.75	416	25466	910259	109653158
Immunodeficiency	75.99	19.75	67	25815	38771	110524646
Cholestatic liver injury	75.10	19.75	36	25846	7340	110556077
Anaemia	74.82	19.75	289	25593	546797	110016620
Urinary retention	68.45	19.75	83	25799	69600	110493817
Head discomfort	68.31	19.75	47	25835	18953	110544464
Listless	68.13	19.75	29	25853	4486	110558931
Activated partial thromboplastin time prolonged	68.11	19.75	50	25832	22318	110541099
Reduced facial expression	67.10	19.75	27	25855	3624	110559793
Creatinine renal clearance decreased	66.96	19.75	49	25833	21766	110541651
Bacteroides infection	65.69	19.75	25	25857	2894	110560523
End stage renal disease	65.38	19.75	48	25834	21425	110541992
Thrombosis	65.22	19.75	102	25780	108560	110454857
Sedation complication	64.13	19.75	46	25836	19809	110543608
Peripheral swelling	62.23	19.75	10	25872	404024	110159393
Drug ineffective	61.70	19.75	169	25713	1520371	109043046
Chronic obstructive pulmonary disease	60.76	19.75	99	25783	109059	110454358
Multiple drug therapy	60.67	19.75	32	25850	7982	110555435
Cognitive disorder	59.41	19.75	87	25795	87424	110475993
Sinusitis	57.10	19.75	3	25879	296685	110266732
Coeliac disease	57.02	19.75	60	25822	43127	110520290
Nausea	56.24	19.75	486	25396	1235204	109328213
Overdose	56.16	19.75	150	25732	233644	110329773
Arthralgia	54.91	19.75	61	25821	779571	109783846
Decreased immune responsiveness	52.60	19.75	31	25851	9575	110553842
Dry mouth	49.76	19.75	130	25752	199818	110363599
Apathy	48.76	19.75	36	25846	16203	110547214
Weight increased	48.12	19.75	19	25863	419625	110143792
Blood calcium decreased	47.68	19.75	50	25832	35795	110527622
Total lung capacity decreased	47.13	19.75	26	25856	7088	110556329
Abdominal discomfort	46.55	19.75	17	25865	393841	110169576
Therapeutic product effect decreased	45.39	19.75	3	25879	244313	110319104
Alopecia	44.38	19.75	15	25867	364738	110198679
Gout	43.36	19.75	48	25834	36518	110526899
Pyrexia	43.23	19.75	358	25524	897907	109665510
Paraesthesia	42.21	19.75	7	25875	276514	110286903
Upper respiratory tract infection	41.89	19.75	94	25788	131234	110432183
Amaurosis fugax	41.61	19.75	17	25865	2373	110561044
Hyperlipidaemia	40.69	19.75	46	25836	35802	110527615
Troponin increased	40.45	19.75	42	25840	29724	110533693
Prescribed overdose	40.27	19.75	73	25809	87508	110475909
Hypokalaemia	39.77	19.75	113	25769	182335	110381082
Dehiscence	38.75	19.75	12	25870	746	110562671
Foreign body	37.91	19.75	17	25865	2978	110560439
Immobile	37.38	19.75	23	25859	7679	110555738
Rash erythematous	37.36	19.75	68	25814	81764	110481653
Ulcer	36.98	19.75	48	25834	43068	110520349
Depressed level of consciousness	35.40	19.75	80	25802	112198	110451219
Orthostatic hypotension	35.39	19.75	59	25823	66190	110497227
Memory impairment	34.93	19.75	3	25879	196941	110366476
Psoriatic arthropathy	34.89	19.75	3	25879	196758	110366659
Blood cholesterol increased	34.17	19.75	108	25774	184677	110378740
Fluid retention	34.07	19.75	71	25811	94236	110469181
Pain in extremity	33.28	19.75	39	25843	487079	110076338
Lung opacity	33.13	19.75	25	25857	11627	110551790
Blood calcium increased	33.06	19.75	30	25852	18010	110545407
Urinary tract disorder	32.37	19.75	19	25863	5825	110557592
Pulmonary embolism	31.45	19.75	116	25766	214358	110349059
Sleep disorder	31.31	19.75	110	25772	198534	110364883
Blister	30.10	19.75	8	25874	227368	110336049
Faecaloma	29.72	19.75	26	25856	14882	110548535
Depression	29.43	19.75	19	25863	317316	110246101
Drug interaction	29.37	19.75	209	25673	499974	110063443
Analgesic therapy	28.52	19.75	19	25863	7265	110556152
Prescription drug used without a prescription	28.18	19.75	17	25865	5479	110557938
Inappropriate antidiuretic hormone secretion	27.96	19.75	37	25845	33814	110529603
Malaise	27.60	19.75	74	25808	671745	109891672
Therapeutic product effect incomplete	27.56	19.75	9	25873	223796	110339621
Musculoskeletal pain	27.12	19.75	5	25877	183018	110380399
Urticaria	27.05	19.75	21	25861	318836	110244581
Chest pain	26.93	19.75	29	25853	376346	110187071
Delirium	26.89	19.75	81	25801	134944	110428473
Fatigue	26.73	19.75	171	25711	1215787	109347630
Nasopharyngitis	26.47	19.75	32	25850	394329	110169088
Therapy non-responder	26.32	19.75	3	25879	157304	110406113
Product dose omission issue	26.29	19.75	22	25860	321760	110241657
Folliculitis	26.13	19.75	4	25878	167649	110395768
Wheezing	25.46	19.75	14	25868	255216	110308201
Osteoarthritis	24.99	19.75	6	25876	182617	110380800
Affect lability	24.79	19.75	26	25856	18611	110544806
Sedation	24.63	19.75	52	25830	69631	110493786
Pneumonia aspiration	24.63	19.75	57	25825	81176	110482241
Injection site pain	24.04	19.75	6	25876	177916	110385501
Arthritis	23.95	19.75	5	25877	167581	110395836
Ill-defined disorder	23.86	19.75	4	25878	156849	110406568
Hypoaesthesia	23.86	19.75	23	25859	314200	110249217
Bronchopulmonary aspergillosis allergic	23.78	19.75	18	25864	8408	110555009
Congenital hiatus hernia	23.72	19.75	16	25866	6243	110557174
Benign prostatic hyperplasia	23.47	19.75	25	25857	18209	110545208
pH body fluid increased	23.08	19.75	5	25877	73	110563344
Pelvic fracture	22.97	19.75	22	25860	14132	110549285
Thrombocytopenia	22.97	19.75	150	25732	348735	110214682
Dyspepsia	22.96	19.75	8	25874	190957	110372460
Intentional product use issue	22.76	19.75	15	25867	247891	110315526
Product prescribing error	22.60	19.75	42	25840	51289	110512128
Pruritus	22.43	19.75	66	25816	581494	109981923
Drug intolerance	22.20	19.75	167	25715	406345	110157072
Fall	22.09	19.75	227	25655	603255	109960162
Fracture	21.89	19.75	28	25854	24760	110538657
Blood test abnormal	21.74	19.75	30	25852	28524	110534893
Hyperhidrosis	21.59	19.75	94	25788	187204	110376213
Liver function test increased	21.42	19.75	57	25825	88491	110474926
Systemic infection	21.35	19.75	18	25864	9801	110553616
Heart rate increased	21.16	19.75	4	25878	143830	110419587
Asthenia	20.68	19.75	87	25795	688912	109874505
Abdominal rigidity	20.48	19.75	12	25870	3668	110559749
Gait disturbance	20.39	19.75	21	25861	278187	110285230
Hepatic function abnormal	20.12	19.75	56	25826	89239	110474178
Maternal exposure during pregnancy	20.12	19.75	18	25864	254865	110308552

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A06AB08	ALIMENTARY TRACT AND METABOLISM DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION Contact laxatives
ATC	A06AB58	ALIMENTARY TRACT AND METABOLISM DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION Contact laxatives
MeSH PA	D002400	Cathartics
MeSH PA	D005765	Gastrointestinal Agents
CHEBI has role	CHEBI:50503	laxative

Related Drugs by ATC class:

A06AB Contact laxatives 6 drugs

bisacodylbisoxatincastor oildantronoxyphenisatinephenolphthalein

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Colonoscopy	indication	73761001

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Patent number	Patent expiration date	Patent use
12GM/BOT;3.5GM/BOT;10MG/BOT	CLENPIQ	FERRING PHARMS INC	N209589	Nov. 28, 2017	RX	SOLUTION	ORAL	11191753	June 23, 2034	FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY
12GM/BOT;3.5GM/BOT;10MG/BOT	CLENPIQ	FERRING PHARMS INC	N209589	Nov. 28, 2017	RX	SOLUTION	ORAL	12576072	June 23, 2034	FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY
12GM/BOT;3.5GM/BOT;10MG/BOT	CLENPIQ	FERRING PHARMS INC	N209589	Nov. 28, 2017	RX	SOLUTION	ORAL	9827231	June 26, 2034	FOR CLEANSING THE LARGE INTESTINE AS A PREPARATION FOR COLONOSCOPY

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
LR57574HN8	UNII
4032318	VUID
N0000186955	NUI
4032318	VANDF
C0071042	UMLSCUI
CHEBI:32147	CHEBI
CHEMBL1697768	ChEMBL_ID
68654	PUBCHEM_CID
C005701	MESH_SUPPLEMENTAL_RECORD_UI
DB14232	DRUGBANK_ID
33688	RXNORM
18056	MMSL
d04939	MMSL
003762	NDDF
317558003	SNOMEDCT_US
395881001	SNOMEDCT_US
C0058139	UMLSCUI
69046	PUBCHEM_CID
1307301-38-7	SECONDARY_CAS_RN

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID	HUMAN PRESCRIPTION DRUG LABEL	3	31722-874	POWDER, METERED	10 mg	ORAL	ANDA	25 sections
CLENPIQ	HUMAN PRESCRIPTION DRUG LABEL	3	55566-6800	LIQUID	10 mg	ORAL	NDA	31 sections